Shares of Global Health Ltd, which operates under the Medanta brand, rose 3.72% to ₹1,376.40 in early trade on Thursday after the company posted robust earnings for the June quarter.
In Q1FY26 (consolidated), Global Health reported a 49.6% YoY jump in net profit to ₹159 crore, compared to ₹106.3 crore in Q1FY25. Revenue grew 19.7% YoY to ₹1,030.8 crore from ₹861.1 crore, driven by higher occupancy and growth across specialties.
The company’s EBITDA margin improved to 22%, up from 21.6% in the year-ago period, reflecting operational efficiencies.
The stock touched an intraday high of ₹1,404 and was trading near its 52-week peak, supported by higher volumes and positive sentiment post-results.
Disclaimer: The views and stock performance updates in this article are for informational purposes only. They do not represent the opinion of Business Upturn and should not be construed as investment advice. Please consult a certified financial advisor before making any investment decisions.
